Belgium vs New Zealand: Proportion of isolates with decreased susceptibility or resistance
Belgium
0.6
in 2020
New Zealand
0.1
in 2020
Belgium rank
10th
New Zealand rank
11th
Proportion of isolates with decreased susceptibility or resistance over time
- Belgium
- New Zealand
How they compare
Belgium currently reports 0.6 against 0.1 in New Zealand, a difference of 0.5.
That makes Belgium's figure about 6.0 times New Zealand's.
The two have swapped places 1 time across 9 shared years of data; in 2009 it was New Zealand ahead.
Belgium ranks 10th and New Zealand ranks 11th of 52 countries.
Across the 3 decades both report, Belgium averaged higher in 1 and New Zealand in 1.
Head to head by decade
| Decade | Belgium | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | — |
| 2010s | 0 | 0.3779 | 0.3779 | New Zealand |
| 2020s | 0.6 | 0.1 | 0.5 | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Belgium or New Zealand?
- Belgium, at 0.6 against 0.1 in New Zealand as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Belgium and New Zealand?
- 0.5, with Belgium ahead.
- How many years of comparable data are there for Belgium and New Zealand?
- 9 years are reported by both, from 2009 to 2020.
- How do Belgium and New Zealand rank globally for proportion of isolates with decreased susceptibility or resistance?
- Belgium ranks 10th and New Zealand ranks 11th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.